Venlafaxine Extended-Release Tablets Recalled for Missing Tablet Identification
Appco Pharma LLC is recalling Venlafaxine Extended-Release Tablets, 150mg, due to missing tablet identification imprints. The defect affects 1,380 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall with no reported illnesses or injuries. The hazard is a manufacturing specification failure—missing tablet identification—classified as a labeling defect rather than a safety hazard with reported harm.
Plain-English summary
Appco Pharma LLC is recalling Venlafaxine Extended-Release Tablets, 150mg (NDC 43598-943-90), Lot #2402101UR, expiration 02/28/2027, due to a manufacturing specification failure. The tablets lack the identification number imprint on either side of the tablet.
The affected product consists of 1,380 bottles distributed nationwide throughout the United States.
The recalled product
- Product
- VENLAFAXINE (VENLAFAXINE)
- Brand
- VENLAFAXINE
- Manufacturer
- Appco Pharma LLC
- Category
- Drug — Antidepressant
- Affected units
- 1,380
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2402101UR
- Exp 02/28/2027
UPCs (4)
- 0343598943909
- 0343598944906
- 0343598944302
- 0343598943305
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · VENLAFAXINE
- HighVenlafaxine Tablets 75 mg Recalled for Foreign Metal Material
FDA (Drugs) · 2025-04-16
- ModerateBryant Ranch Recalls Venlafaxine Tablets Due to Labeling Error
FDA (Drugs) · 2016-05-11
- ModerateZydus Recalls Venlafaxine Hydrochloride Tablets Due to Broken Tablets
FDA (Drugs) · 2013-04-03
Same manufacturer · Appco Pharma LLC
See all →- HighPrazosin hydrochloride 100-count bottles recalled over nitrosamine impurity
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride further lots recalled over nitrosamine impurity levels
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride tablets recalled over nitrosamine impurity above limits
FDA (Drugs) · 2026-04-08
- SevereAppco Pharma Recalls Ranitidine Capsules Due to NDMA Impurity
FDA (Drugs) · 2020-01-15
- SevereAppco Pharma Recalls Ranitidine Capsules Due to NDMA Impurity
FDA (Drugs) · 2020-01-15
Same hazard · missing imprint
See all →- ModerateOxycodone and acetaminophen 10 mg tablets recalled over a missing imprint
FDA (Drugs) · 2026-01-14
- ModerateOxycodone and acetaminophen 7.5 mg tablets recalled over a missing imprint
FDA (Drugs) · 2026-01-14
- ModerateAcetaminophen 325 mg tablets recalled for missing imprint
FDA (Drugs) · 2022-08-24
- ModerateAkorn Pharma recalls Acetaminophen 500 mg tablets with missing imprints
FDA (Drugs) · 2022-08-24